-
Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo in Resectable Non-Small Cell Lung Cancer
07 Feb 2024 12:27 GMT
… cancers to date, including lung cancer, bladder cancer, esophageal … response (MPR).
About Lung Cancer
Lung cancer is the leading … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … lung cancer; Checkmate 816-neoadjuvant non-small cell lung cancer, …
-
NuCana Announces Plan to Implement ADS Ratio Change
27 Mar 2024 20:50 GMT
… combination with leucovorin, irinotecan or oxaliplatin, and bevacizumab in patients with … with docetaxel for patients with lung cancer. NUC-7738 is a transformation …
-
NuCana Announces Plan to Implement ADS Ratio Change
27 Mar 2024 20:30 GMT
… combination with leucovorin, irinotecan or oxaliplatin, and bevacizumab in patients with … with docetaxel for patients with lung cancer. NUC-7738 is a transformation …
-
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy
27 Mar 2024 01:49 GMT
… -squamous non-small cell lung cancer lacking EGFR or ALK … -squamous non-small cell lung cancer who progressed after EGFR- … metastatic squamous non-small cell lung cancer; For the first-line … Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III …
-
The Relationship Between the Expression of circFAT1 and Immune Cell in Patients with Non-Small Cell Lung Cancer
31 Oct 2023 03:22 GMT
… small cell lung cancer (NSCLC) accounts for 85% of lung cancer cases. … in non-small cell lung cancer: gene regulation, impact … in non-small cell lung cancer: mechanistic insights and therapeutic … (SKA1) axis regulates oxaliplatin resistance in breast cancer …
-
The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients
25 Mar 2024 10:25 GMT
… effect of endostar combined with oxaliplatin in the treatment of primary … -positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled … Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med. 2015 …
-
Neoadjuvant Opdivo (nivolumab) with Chemotherapy Provides Benefits for Patients with Resectable Non-Small Cell Lung Cancer Across PD-L1 Expression Levels with Three-Year Follow Up in CheckMate -816 Trial
17 Oct 2023 20:05 GMT
… tumor types, including lung cancer, bladder cancer, esophageal … distant metastases.
About Lung Cancer
Lung cancer is the leading … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Perioperative Regimen of Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo Shows Significant Improvement in Event-Free Survival for Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -77T Trial
17 Oct 2023 19:36 GMT
… of four tumor types: lung cancer, bladder cancer, esophageal … response (MPR).
About Lung Cancer
Lung cancer is the leading cause … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Bristol Myers Squibb Announces Perioperative Regimen of Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo Significantly Improves Event-Free Survival in Patients with Resectable Non-Small Cell Lung Cancer
22 Sep 2023 11:10 GMT
… of four tumor types: lung cancer, bladder cancer, esophageal … response (MPR).
About Lung Cancer
Lung cancer is the leading cause … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Six-Year Outcomes from Phase 3 CheckMate -227 Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer
11 Sep 2023 11:28 GMT
… L1 ≥1%.
About Lung Cancer
Lung cancer is the leading cause … positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …